Stress-induced rupioid psoriasis managed with ustekinumab
Skin Health and Disease · 29.05.2026 · 6 (3) · 361-362
DOI: 10.1093/skinhd/vzag018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Health and Disease, online erschienen am 25.03.2026. Verfasst von Gustavo Almeida-Silva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Unidade Local de Saúde Santa Maria, Lisbon, Portugal. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We report the first case of stress-induced rupioid psoriasis, a rare and severe hyperkeratotic variant of psoriasis, arising after the sudden loss of a close relative. The patient achieved remarkable clearance with ustekinumab, highlighting the potential of interleukin (IL)-12/IL-23 blockade in this under-recognized phenotype. This case underscores the role of acute stress as a trigger, and the urgent need to better define the pathophysiology and tailored treatment of hyperkeratotic psoriasis variants.
Autor:innen und Institutionen
- Dermatology Department, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.
- Dermatology University Clinic, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
ORCID-Profile: Gustavo Almeida-Silva
Zitieren
APA
Almeida-Silva, G., & Antunes, J. (2026). Stress-induced rupioid psoriasis managed with ustekinumab. Skin Health and Disease, 6(3), 361-362. https://doi.org/10.1093/skinhd/vzag018
Vancouver
Almeida-Silva G, Antunes J. Stress-induced rupioid psoriasis managed with ustekinumab. Skin Health and Disease. 2026;6(3):361-362. doi:10.1093/skinhd/vzag018
BibTeX
@article{AlmeidaSilva2026,
author = {Almeida-Silva, Gustavo and Antunes, Joana},
title = {Stress-induced rupioid psoriasis managed with ustekinumab},
journal = {Skin Health and Disease},
year = {2026},
volume = {6},
number = {3},
pages = {361--362},
doi = {10.1093/skinhd/vzag018}
}
EUVIMED